VRNA vs. EUAD

Last updated Jun 13, 2026

VRNA (Verona Pharma plc) is a stock, while EUAD (Select STOXX Europe Aerospace & Defense ETF) is Aerospace & Defense fund tracking the STOXX Europe Total Market Aerospace & Defense Index. At a 0.08 correlation, their price movements are largely independent.

Performance

VRNA vs. EUAD - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Verona Pharma plc (VRNA) and Select STOXX Europe Aerospace & Defense ETF (EUAD). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

VRNA

• 1D: —
• 1M: —
• YTD: —
• 6M: —
• 1Y: —
• 3Y*: —
• 5Y*: —
• 10Y*: —

EUAD

• 1D: -0.77%
• 1M: 4.47%
• YTD: -2.37%
• 6M: -0.54%
• 1Y: 2.75%
• 3Y*: —
• 5Y*: —
• 10Y*: —

*Multi-year figures are annualized to reflect compound growth (CAGR)

VRNA vs. EUAD - Yearly Performance Comparison

	2026 (YTD)	2025	2024
VRNA Verona Pharma plc	0.00%	130.21%	32.80%
EUAD Select STOXX Europe Aerospace & Defense ETF	-2.37%	74.51%	-6.86%

Correlation

The correlation between VRNA and EUAD is -0.00, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	-0.00
Correlation (All Time) Calculated using the full available price history since Oct 22, 2024	0.08

Return for Risk

VRNA vs. EUAD — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

VRNA

Risk / return metrics aren't available yet — we need at least 12 months of trading data to calculate them.

EUAD

EUAD Risk / Return Rank: 11
EUAD Sharpe Ratio Rank: 11
EUAD Sortino Ratio Rank: 11
EUAD Omega Ratio Rank: 11
EUAD Calmar Ratio Rank: 11
EUAD Martin Ratio Rank: 11

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

VRNA vs. EUAD - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Verona Pharma plc (VRNA) and Select STOXX Europe Aerospace & Defense ETF (EUAD). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.

	VRNA	EUAD	Difference
Sharpe ratio: Return per unit of total volatility	—	0.09	—
Sortino ratio: Return per unit of downside risk	—	0.35	—
Omega ratio: Gain probability vs. loss probability	—	1.04	—
Calmar ratio: Return relative to maximum drawdown	—	0.13	—
Martin ratio: Return relative to average drawdown	—	0.30	—

Drawdowns

Drawdown Indicators

	VRNA	EUAD	Difference
Max Drawdown Largest peak-to-trough decline	—	-22.04%	—
Max Drawdown (1Y) Largest decline over 1 year	—	-22.04%	—
Current Drawdown Current decline from peak	—	-14.81%	—
Average Drawdown Average peak-to-trough decline	—	-5.88%	—
Ulcer Index Depth and duration of drawdowns from previous peaks	—	9.34%	—

Volatility

Volatility by Period

	VRNA	EUAD	Difference
Volatility (1M) Calculated over the trailing 1-month period	—	9.65%	—
Volatility (6M) Calculated over the trailing 6-month period	—	24.40%	—
Volatility (1Y) Calculated over the trailing 1-year period	—	29.15%	—
Volatility (5Y) Calculated over the trailing 5-year period, annualized	—	29.90%	—
Volatility (10Y) Calculated over the trailing 10-year period, annualized	—	29.90%	—

Dividends

VRNA vs. EUAD - Dividend Comparison

VRNA has not paid dividends to shareholders, while EUAD's dividend yield for the trailing twelve months is around 0.41%.

Position	TTM	2025	2024
EUAD Select STOXX Europe Aerospace & Defense ETF	0.41%	0.40%	0.10%
VRNA Verona Pharma plc	0.00%	0.00%	0.00%

Frequently Asked Questions

Can I hold both VRNA and EUAD in my portfolio?

VRNA and EUAD have a correlation of -0.00, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.